Hwang Si Moon 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 26, 2012
Insider Transaction Report
Form 4
Hwang Si Moon
Director
Transactions
- Award
Stock Options (right-to-buy)
2012-06-18+20,000→ 20,000 totalExercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Holdings
- 7,000(indirect: By daughter)
Common Stock
- 7,000(indirect: By Son)
Common Stock
- 341,198
Common Stock
- 7,000(indirect: By daughter)
Common Stock
Footnotes (1)
- [F1]These options vest and become exercisable in full on June 18, 2013.